.

Pharmaceutical Business Intelligence

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Primaquine phosphate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for primaquine phosphate?

Primaquine phosphate is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us, Alvogen Inc, Ingenus Pharms Nj, and Bayshore Pharms Llc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for primaquine phosphate. Eight suppliers are listed for this compound.

Summary for Generic Name: primaquine phosphate

Tradenames:2
Patents:1
Applicants:4
NDAs:4
Drug Master File Entries: see list4
Suppliers / Packagers: see list8
Bulk Api Vendors: see list100
Clinical Trials: see list397
Patent Applications: see list1,903
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:primaquine phosphate at DailyMed

Pharmacology for Ingredient: primaquine phosphate

Drug ClassAntimalarial
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayshore Pharms Llc
PRIMAQUINE PHOSPHATE
primaquine phosphate
TABLET;ORAL204476-001Feb 25, 2014RXNoNo► Subscribe► Subscribe
Ingenus Pharms Nj
PRIMAQUINE PHOSPHATE
primaquine phosphate
TABLET;ORAL206043-001Jun 23, 2016RXNoNo► Subscribe► Subscribe
Sanofi Aventis Us
PRIMAQUINE
primaquine phosphate
TABLET;ORAL008316-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Alvogen Inc
PRIMAQUINE PHOSPHATE
primaquine phosphate
TABLET;ORAL203924-001Feb 3, 2014RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc